Skip to main content
Erschienen in: Journal of Clinical Monitoring and Computing 5/2016

18.08.2015 | Original Research

Algorithms that eliminate the effects of calibration artefact and trial-imposed offsets of Masimo oximeter in BOOST-NZ trial

verfasst von: Marina Zahari, Dominic Savio Lee, Brian Alexander Darlow

Erschienen in: Journal of Clinical Monitoring and Computing | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

The displayed readings of Masimo pulse oximeters used in the Benefits Of Oxygen Saturation Targeting (BOOST) II and related trials in very preterm babies were influenced by trial-imposed offsets and an artefact in the calibration software. A study was undertaken to implement new algorithms that eliminate the effects of offsets and artefact. In the BOOST-New Zealand trial, oxygen saturations were averaged and stored every 10 s up to 36 weeks’ post-menstrual age. Two-hundred and fifty-seven of 340 babies enrolled in the trial had at least two weeks of stored data. Oxygen saturation distribution patterns corresponding with a +3 % or −3 % offset in the 85–95 % range were identified together with that due to the calibration artefact. Algorithms involving linear and quadratic interpolations were developed, implemented on each baby of the dataset and validated using the data of a UK preterm baby, as recorded from Masimo oximeters with the original software and a non-offset Siemens oximeter. Saturation distributions obtained were compared for both groups. There were a flat region at saturations 85–87 % and a peak at 96 % from the lower saturation target oximeters, and at 93–95 and 84 % respectively from the higher saturation target oximeters. The algorithms lowered the peaks and redistributed the accumulated frequencies to the flat regions and artefact at 87–90 %. The resulting distributions were very close to those obtained from the Siemens oximeter. The artefact and offsets of the Masimo oximeter’s software had been addressed to determine the true saturation readings through the use of novel algorithms. The implementation would enable New Zealand data be included in the meta-analysis of BOOST II trials, and be used in neonatal oxygen studies.
Literatur
2.
Zurück zum Zitat Askie LM, Henderson-Smart DH. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev. 2001;4:CD001077.PubMed Askie LM, Henderson-Smart DH. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev. 2001;4:CD001077.PubMed
3.
Zurück zum Zitat Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.CrossRefPubMed Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.CrossRefPubMed
4.
Zurück zum Zitat Silverman WA. A cautionary tale about supplemental oxygen: the albatross of neonatal medicine. Pediatrics. 2004;113:394–6.CrossRefPubMed Silverman WA. A cautionary tale about supplemental oxygen: the albatross of neonatal medicine. Pediatrics. 2004;113:394–6.CrossRefPubMed
5.
Zurück zum Zitat Askie LM, Brocklehurst P, Darlow BA, et al. NeOProM: neonatal oxygenation prospective meta-analysis collaboration study protocol. BMC Pediatr. 2011;11:6.CrossRefPubMedPubMedCentral Askie LM, Brocklehurst P, Darlow BA, et al. NeOProM: neonatal oxygenation prospective meta-analysis collaboration study protocol. BMC Pediatr. 2011;11:6.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Darlow BA, Marschner S, Donoghoe M, et al. Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes. J Pediatr. 2014;165:30–5.CrossRefPubMed Darlow BA, Marschner S, Donoghoe M, et al. Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes. J Pediatr. 2014;165:30–5.CrossRefPubMed
7.
Zurück zum Zitat Johnston ED, Boyle B, Juszczak E, et al. Oxygen targeting in preterm infants using the Masimo SET Radical pulse oximeter. Arch Dis Child Fetal Neonat Ed. 2011;96:F429–33.CrossRef Johnston ED, Boyle B, Juszczak E, et al. Oxygen targeting in preterm infants using the Masimo SET Radical pulse oximeter. Arch Dis Child Fetal Neonat Ed. 2011;96:F429–33.CrossRef
8.
Zurück zum Zitat Schmidt B, Whyte RK, Asztalos EV, Canadian Oxygen Trial (COT) Group, et al. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA. 2013;309:2111–20.CrossRefPubMed Schmidt B, Whyte RK, Asztalos EV, Canadian Oxygen Trial (COT) Group, et al. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA. 2013;309:2111–20.CrossRefPubMed
9.
Zurück zum Zitat The BOOST II UK, Australia and New Zealand Collaborative Groups, Stenson BJ, Tarnow-Mordi WO, Darlow BA, et al. Oxygen saturation and outcomes in preterm infants. N Engl J Med. 2013;368:2094–104.CrossRef The BOOST II UK, Australia and New Zealand Collaborative Groups, Stenson BJ, Tarnow-Mordi WO, Darlow BA, et al. Oxygen saturation and outcomes in preterm infants. N Engl J Med. 2013;368:2094–104.CrossRef
10.
Zurück zum Zitat SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo WA, Finer NN, Walsh MC, et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010;362:1959–69.CrossRefPubMedCentral SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo WA, Finer NN, Walsh MC, et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010;362:1959–69.CrossRefPubMedCentral
11.
Zurück zum Zitat Vaucher YE, Peralta-Carcelen M, Finer NN, et al. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med. 2012;367:2495–504.CrossRefPubMedPubMedCentral Vaucher YE, Peralta-Carcelen M, Finer NN, et al. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med. 2012;367:2495–504.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Cunningham S, Mclntosh N, Fleck BW, et al. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet. 1995;346:1464–5.CrossRefPubMed Cunningham S, Mclntosh N, Fleck BW, et al. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet. 1995;346:1464–5.CrossRefPubMed
13.
Zurück zum Zitat York JR, Landers S, Kirby RS, et al. Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol. 2004;24:82–7.CrossRefPubMed York JR, Landers S, Kirby RS, et al. Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol. 2004;24:82–7.CrossRefPubMed
14.
Zurück zum Zitat Schmidt B, Whyte RK, Asztalos EV, Canadian Oxygen Trial (COT) Group, et al. Masking algorithm of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA. 2014;309:2111–20.CrossRef Schmidt B, Whyte RK, Asztalos EV, Canadian Oxygen Trial (COT) Group, et al. Masking algorithm of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA. 2014;309:2111–20.CrossRef
Metadaten
Titel
Algorithms that eliminate the effects of calibration artefact and trial-imposed offsets of Masimo oximeter in BOOST-NZ trial
verfasst von
Marina Zahari
Dominic Savio Lee
Brian Alexander Darlow
Publikationsdatum
18.08.2015
Verlag
Springer Netherlands
Erschienen in
Journal of Clinical Monitoring and Computing / Ausgabe 5/2016
Print ISSN: 1387-1307
Elektronische ISSN: 1573-2614
DOI
https://doi.org/10.1007/s10877-015-9752-1

Weitere Artikel der Ausgabe 5/2016

Journal of Clinical Monitoring and Computing 5/2016 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.